Accelerator's Spaltudaq Receives About $1.2M In Series A Capital

Accelerator Corp., an incubator focused on systems biology start-ups, said it
invested in its third company, Spaltudaq Corp., which is developing
tumor-specific cancer antibody-based therapeutics.